Ian T Clark is Director of Guardant Health, Inc.. Currently has a direct ownership of 0 shares of GH, which is worth approximately $0. The most recent transaction as insider was on Nov 12, 2024, when has been sold 8,435 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

IAN T CLARK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 12 2024
SELL
Other acquisition or disposition
-
8,435 Reduced 100.0%
0 Common Stock
Nov 12 2024
SELL
Open market or private sale
$245,214 $29.48 p/Share
8,318 Reduced 49.65%
8,435 Common Stock
Nov 12 2024
BUY
Exercise of conversion of derivative security
$4,497 $4.18 p/Share
1,076 Added 6.04%
16,753 Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
6,776 Added 30.18%
15,677 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
-
6,703 Added 42.96%
8,901 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
-
2,198 Added 50.0%
2,198 Common Stock
Sep 01 2021
SELL
Open market or private sale
$139,880 $130.0 p/Share
1,076 Reduced 100.0%
0 Common Stock
Sep 01 2021
BUY
Exercise of conversion of derivative security
$4,498 $4.18 p/Share
1,076 Added 50.0%
1,076 Common Stock
Jun 29 2021
SELL
Open market or private sale
$1,372,670 $130.0 p/Share
10,559 Reduced 100.0%
0 Common Stock
Jun 29 2021
BUY
Exercise of conversion of derivative security
$240,367 $40.63 p/Share
5,916 Added 35.91%
10,559 Common Stock
Apr 26 2021
SELL
Open market or private sale
$86,037 $159.92 p/Share
538 Reduced 10.38%
4,643 Common Stock
Apr 26 2021
BUY
Exercise of conversion of derivative security
$2,249 $4.18 p/Share
538 Added 9.41%
5,181 Common Stock
Mar 25 2021
SELL
Open market or private sale
$71,064 $132.09 p/Share
538 Reduced 10.38%
4,643 Common Stock
Mar 25 2021
BUY
Exercise of conversion of derivative security
$2,249 $4.18 p/Share
538 Added 9.41%
5,181 Common Stock
Feb 25 2021
SELL
Open market or private sale
$82,852 $154.0 p/Share
538 Reduced 10.38%
4,643 Common Stock
Feb 25 2021
BUY
Exercise of conversion of derivative security
$2,249 $4.18 p/Share
538 Added 9.41%
5,181 Common Stock
Jan 25 2021
SELL
Open market or private sale
$87,156 $162.0 p/Share
538 Reduced 10.38%
4,643 Common Stock
Jan 25 2021
BUY
Exercise of conversion of derivative security
$2,249 $4.18 p/Share
538 Added 9.41%
5,181 Common Stock
Jan 04 2021
SELL
Open market or private sale
$347,629 $129.23 p/Share
2,690 Reduced 36.68%
4,643 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$11,244 $4.18 p/Share
2,690 Added 26.84%
7,333 Common Stock
Dec 28 2020
SELL
Open market or private sale
$72,630 $135.0 p/Share
538 Reduced 10.38%
4,643 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$2,249 $4.18 p/Share
538 Added 9.41%
5,181 Common Stock
Dec 03 2020
SELL
Open market or private sale
$322,800 $120.0 p/Share
2,690 Reduced 36.68%
4,643 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$11,244 $4.18 p/Share
2,690 Added 26.84%
7,333 Common Stock
Nov 25 2020
SELL
Open market or private sale
$60,945 $113.28 p/Share
538 Reduced 10.38%
4,643 Common Stock

Also insider at

OLMA
Olema Pharmaceuticals, Inc. Healthcare
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
AVRO
AVROBIO, Inc. Healthcare
CRVS
Corvus Pharmaceuticals, Inc. Healthcare
GDRX
GoodRx Holdings, Inc. Healthcare
ITC

Ian T Clark

Director
Burlingame, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH